Services of MTRC
03
Aug 2021
A syndicated report (135 pages) reviews details of innovation funding and coverage with evidence development schemes in Europe, including Austria, Belgium, England, France, Germany, the Netherlands, and Switzerland. For each scheme, information about objective, inclusion criteria, applicant, stakeholders involved, clinical and economic evidence requirements, and statistics (including at least 2019-2020 data; but for most schemes – statistics for multiple years) is included.
Read more
12
Jul 2021
MTRC released an update of the syndicated report on reimbursement decisions for IVD tests in 5 EU countries (Belgium, France, Germany, the Netherlands, and Switzerland). The updated report covers 3-year period of 2018-2020. Broader coverage gives a better understanding of the activity of the reimbursement organizations.
Read more
17
May 2021
In August, MTRC launched two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. You can request a free-of-charge 2-month sample of reporting for both services
Read more
22
Mar 2021
In January 2021, we performed the first annual survey of our customers to synch with our internal knowledge about key developments in the area of market access in European countries. This brief (15 slides) report includes an overview of key developments of reimbursement systems in 2020 and anticipated changes in 2021. Ten countries are included: Belgium, Denmark, England, France, Germany, the Netherlands, Norway, Russia, Sweden and Switzerland.
Read more
03
Dec 2020
The ultimate step in establishing reimbursement is achieved by making reimbursement applications to authorities. MTRC provides support with the development of reimbursement applications for a novel procedure code, change of diagnosis-related groups (DRGs) and establishing other payment mechanisms in the Nordic region and Russia.
Read more
03
Dec 2020
Procedure volume information is crucial to develop an understanding of the market size, frequency of use of alternative / competitor procedures. MTRC provides procedure volume analysis using national administrative databases in Austria, Belgium, England, Finland, France, Germany, the Netherlands, Norway, Sweden and Switzerland.
Read more
02
Nov 2020
MTRC maintains two subscription services with a focus on all published, initiated or ongoing HTA and reimbursement reports and decisions for medical devices, procedures and IVD tests. HTA Alerts is a global service and covers 56 organizations from 24 countries. Reimbursement Alerts is focused on 14 key European countries. All alerts are tailed to the technologies of interest for each client. First EU issues of both newsletters are available for download free-of-charge.
Read more
26
Oct 2020
MTRC has started a subscription service with email alerts about initiated, published and ongoing health technology assessments of pharmaceuticals, gene and cell therapies, as well as vaccines from 56 HTA organizations globally (24 countries).
Read more
14
Sep 2020
The first issue of HTA Alerts included 186 reports from European organizations only. This issue included reports, published or initiated from the 1st of August 2020, and ongoing reports. The most common technological fields were cardiovascular, gastroenterology, in-vitro diagnostics, men's health, neuromodulation, and orthopedics. Contact us if you want to receive a sample alert and to learn more about the service.
Read more
07
Aug 2020
The focus of the service is on reimbursement decisions (new procedure codes, DRG change, coverage decisions, innovation funding, clinical guidelines) in 14 European countries and globally. Only in Europe, 29 organizations are monitored. All news are classified by 31 Technology Group and alerts are sent every 2 weeks. This is a twin service for "HTA Alerts", where we track initiated or published HTAs from 56 organizations globally.
Read more
27
Jul 2020
For the last three years, MTRC maintained a be-weekly newsletter with information about reimbursement and market access changes in European countries. From July 2020, we are extending this activity with an introduction of the paid subscription service HTA Alerts. It will include bi-weekly reports about initiated or published HTAs from 56 HTA organizations worldwide. Reports will be customized so that the clients receive notification for only relevant technologies.
Read more
29
Jun 2020
The report summarizes information about HTA activity in 12 European countries (+EUnetHTA), including 51 HTA organizations. Data for all non-pharmaceutical published HTAs in 2019 are reported. In total, 256 reports are reported (in 2018, 337 reports were released by the same organizations). The largest number of reports were published in England (108 reports, 42%), Sweden (34 reports, 13%) and Spain (26 reports, 10%). All reports are classified using 31 technological groups. The most common types of technologies covered by HTA reports were in-vitro diagnostic (38 reports, 15%) and cardiovascular (25 reports, 10%) ones.
Read more